FHIR © HL7.org | Server Home | FHIR Server FHIR Server 3.7.12 | FHIR Version n/a User: [n/a]

35990511000001101: Methyldopa 250mg tablets (Ennogen Pharma Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Methyldopa 250mg tablets (Ennogen Pharma Ltd)
\UK product\Virtual medicinal product\Product containing precisely methyldopa 250 milligram/1 each conventional release oral tablet\Methyldopa 250mg tablets (Ennogen Pharma Ltd)
\UK product\Virtual therapeutic moiety\Methyldopa\Product containing only methyldopa in oral dose form (medicinal product form)\Product containing precisely methyldopa 250 milligram/1 each conventional release oral tablet\Methyldopa 250mg tablets (Ennogen Pharma Ltd)
\UK product\Virtual therapeutic moiety\Methyldopa\Product containing precisely methyldopa 250 milligram/1 each conventional release oral tablet\Methyldopa 250mg tablets (Ennogen Pharma Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Nov 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

111159201000001112 Methyldopa 250mg tablets (Ennogen Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

111159301000001115 Methyldopa 250mg tablets (Ennogen Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Methyldopa 250mg tablets (Ennogen Pharma Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Methyldopa 250mg tablets (Ennogen Pharma Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Methyldopa 250mg tablets (Ennogen Pharma Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Methyldopa 250mg tablets (Ennogen Pharma Ltd)	Is a	Product containing precisely methyldopa 250 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Methyldopa 250mg tablets (Ennogen Pharma Ltd)	Has manufactured dose form	Tablet	false	Inferred relationship	Existential restriction modifier
Methyldopa 250mg tablets (Ennogen Pharma Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Methyldopa 250mg tablets (Ennogen Pharma Ltd)	Has basis of strength substance	Methyldopa	true	Inferred relationship	Existential restriction modifier	1
Methyldopa 250mg tablets (Ennogen Pharma Ltd)	Has presentation strength numerator value	250	false	Inferred relationship	Existential restriction modifier	1
Methyldopa 250mg tablets (Ennogen Pharma Ltd)	Has presentation strength numerator unit	milligram	true	Inferred relationship	Existential restriction modifier	1
Methyldopa 250mg tablets (Ennogen Pharma Ltd)	Has presentation strength denominator value	1	false	Inferred relationship	Existential restriction modifier	1
Methyldopa 250mg tablets (Ennogen Pharma Ltd)	Has presentation strength denominator unit	Tablet	true	Inferred relationship	Existential restriction modifier	1
Methyldopa 250mg tablets (Ennogen Pharma Ltd)	Has precise active ingredient	Methyldopa	true	Inferred relationship	Existential restriction modifier	1
Methyldopa 250mg tablets (Ennogen Pharma Ltd)	Has unit of presentation	Tablet	true	Inferred relationship	Existential restriction modifier
Methyldopa 250mg tablets (Ennogen Pharma Ltd)	Count of base of active ingredient	1	false	Inferred relationship	Existential restriction modifier
Methyldopa 250mg tablets (Ennogen Pharma Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Methyldopa 250mg tablets (Ennogen Pharma Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Methyldopa 250mg tablets (Ennogen Pharma Ltd)	Has specific active ingredient	Methyldopa	true	Inferred relationship	Existential restriction modifier
Methyldopa 250mg tablets (Ennogen Pharma Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Methyldopa 250mg tablets (Ennogen Pharma Ltd)	Has excipient	Lactose	false	Inferred relationship	Existential restriction modifier
Methyldopa 250mg tablets (Ennogen Pharma Ltd)	Has excipient	Tartrazine stain	false	Inferred relationship	Existential restriction modifier
Methyldopa 250mg tablets (Ennogen Pharma Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Methyldopa 250mg tablets (Ennogen Pharma Ltd) 56 tablet	Has AMP	True	Methyldopa 250mg tablets (Ennogen Pharma Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
111159201000001112	Methyldopa 250mg tablets (Ennogen Pharma Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
111159301000001115	Methyldopa 250mg tablets (Ennogen Pharma Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module